Comparative Study Between Generic and Ethical Drugs

Clicks: 1
ID: 309230
2024
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #128 of 153 articles by views in International Journal of Pharmaceutical Drug Design (IJPDD)

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 153 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
The pharmaceutical landscape is marked by the coexistence of two essential categories of drugs: generic and branded. This review article aims to comprehensively analyze the key aspects, including efficacy, safety, cost-effectiveness, and regulatory considerations, in the ongoing debate surrounding generic and branded drugs. This study systematically evaluates a vast body of literature and clinical trials, encompassing various therapeutic areas and disease conditions, to elucidate the similarities and differences between generic and branded pharmaceuticals. We explore the bioequivalence and quality control measures that underpin generic drug manufacturing, shedding light on their safety and effectiveness. Furthermore, this review delves into the cost-effectiveness of generic drugs, addressing their potential to reduce healthcare expenditure while maintaining therapeutic efficacy. We also discuss the impact of healthcare policies and regulations on the prescription and utilization of generic drugs across different regions. Through this comparative analysis, we aim to provide healthcare professionals, policymakers, and patients with a balanced perspective on the choice between generic and branded drugs. Our findings highlight the importance of individual patient needs, regulatory compliance, and healthcare infrastructure in shaping drug selection and utilization. Ultimately, this review underscores the significance of continued research and evidence-based decision-making in optimizing the use of generic and branded drugs, thereby enhancing healthcare outcomes and promoting accessible, affordable, and high-quality pharmaceutical care for patients worldwide.
Reference Key
imported_1761926692_6904de24cba8b Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Shruti Singh Sengar, Dinesh Kumar Jain*
Journal International Journal of Pharmaceutical Drug Design (IJPDD)
Year 2024
DOI
10.62896/ijpdd.1.7.2
URL
https://ijpdd.org/index.php/files/article/view/147
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.